Literature DB >> 28397624

Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile.

Cara M Cannon1, Jackson S Musuuza2, Anna K Barker1, Megan Duster3, Mark B Juckett4, Aurora E Pop-Vicas3, Nasia Safdar3.   

Abstract

The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions. Infect Control Hosp Epidemiol 2017;38:718-720.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28397624      PMCID： PMC5531265          DOI： 10.1017/ice.2017.48

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

1.  Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: a modeling evaluation.

Authors:  Cristina Lanzas; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2014-06-20       Impact factor: 3.254

2.  Clostridium difficile in a children's hospital: assessment of environmental contamination.

Authors:  Simone Warrack; Megan Duster; Sarah Van Hoof; Michelle Schmitz; Nasia Safdar
Journal:  Am J Infect Control       Date:  2014-04-18       Impact factor: 2.918

3.  International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.

Authors:  Stuart Johnson; Susan P Sambol; Jon S Brazier; Michel Delmée; V Avesani; Michelle M Merrigan; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.

Authors:  Jackrapong Bruminhent; Zi-Xuan Wang; Carol Hu; John Wagner; Richard Sunday; Brent Bobik; Sarah Hegarty; Scott Keith; Seyfettin Alpdogan; Matthew Carabasi; Joanne Filicko-O'Hara; Neal Flomenberg; Margaret Kasner; Ubaldo Martinez Outschoorn; Mark Weiss; Phyllis Flomenberg
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-02       Impact factor: 5.742

Review 5.  Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.

Authors:  Ioannis M Zacharioudakis; Fainareti N Zervou; Elina Eleftheria Pliakos; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  Am J Gastroenterol       Date:  2015-03-03       Impact factor: 10.864

6.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

7.  Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.

Authors:  Alexander J Kallen; Angela Thompson; Polly Ristaino; Leigh Chapman; Ainsley Nicholson; Bich-Thuy Sim; Fernanda Lessa; Umid Sharapov; Elaine Fadden; Richard Boehler; Carolyn Gould; Brandi Limbago; David Blythe; L Clifford McDonald
Journal:  Infect Control Hosp Epidemiol       Date:  2009-03       Impact factor: 3.254

8.  Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.

Authors:  Tania Jain; Christopher Croswell; Varinia Urday-Cornejo; Reda Awali; Jessica Cutright; Hossein Salimnia; Harsha Vardhan Reddy Banavasi; Alyssa Liubakka; Paul Lephart; Teena Chopra; Sanjay G Revankar; Pranatharthi Chandrasekar; George Alangaden
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-26       Impact factor: 5.742

Review 9.  Antimicrobial-associated risk factors for Clostridium difficile infection.

Authors:  Robert C Owens; Curtis J Donskey; Robert P Gaynes; Vivian G Loo; Carlene A Muto
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study.

Authors:  Linda A Selvey; Claudia Slimings; David J L Joske; Thomas V Riley
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240
  10 in total
  6 in total

1.  Multi-organism gastrointestinal polymerase chain reaction positivity among pediatric transplant vs non-transplant populations: A single-center experience.

Authors:  John M Stone; Andrew Savage; Michelle Hudspeth; Katherine Twombley; Nagraj Kasi; Jose Antonio Quiros; Ricardo A Arbizu; Scott Curry
Journal:  Pediatr Transplant       Date:  2020-07-08

Review 2.  Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.

Authors:  Elizabeth Ann Misch; Nasia Safdar
Journal:  Infect Dis Clin North Am       Date:  2019-06       Impact factor: 5.982

3.  Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors:  Alex Ganetsky; Jennifer H Han; Mitchell E Hughes; Daria V Babushok; Noelle V Frey; Saar I Gill; Elizabeth O Hexner; Alison W Loren; Selina M Luger; James K Mangan; Mary Ellen Martin; Jacqueline Smith; Craig W Freyer; Cheryl Gilmar; Mindy Schuster; Edward A Stadtmauer; David L Porter
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

4.  Prevalence of Clostridium difficile Infection in the Hematopoietic Transplantation Setting: Update of Systematic Review and Meta-Analysis.

Authors:  Ying Luo; Sumei Zhang; Hua Shang; Weitong Cui; Qinglu Wang; Bin Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-21       Impact factor: 5.293

5.  Detection of toxigenic Clostridium difficile colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation.

Authors:  John L Vaughn; Joan-Miquel Balada-Llasat; Misty Lamprecht; Ying Huang; Mirela Anghelina; Zeinab El Boghdadly; Karen Bishop-Hill; Rachel Childs; Preeti Pancholi; Leslie A Andritsos
Journal:  J Med Microbiol       Date:  2018-07       Impact factor: 2.472

6.  Clostridium difficile Colonization Before and After Hospitalization in Children.

Authors:  Türkay Rzayev; Pelin Yüksel Mayda; Tülay Erkan; Bekir Kocazeybek; Tufan Kutlu
Journal:  Turk Arch Pediatr       Date:  2021-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.